Authoritative

We cover strong, credible research studies published in peer-reviewed journals and presented at society congresses, providing accurate, informed reporting of the authors’ findings.

The trusted medical
news you need NOW

Relevant

We go beyond the research results to bring context, highlighting the clinical impact and providing expert opinion to enhance healthcare professionals’ knowledge.

The trusted medical
news you need NOW

Convenient

Our services are timely and easily accessible, ensuring the latest medical advances reach healthcare professionals in a convenient and compelling way.

Reporting on the latest medical advances and opinion to engage and inform healthcare professionals in convenient, easily accessible and timely formats

medwireNews combines scientific expertise with journalistic skills to review the latest research and clinical results across multiple specialties. We report on the most relevant advances to ensure our content is helpful and impactful for a broad range of specialist audiences.

To provide compelling, on-point content, we collaborate with therapy-area experts to deliver key messages that meet the educational needs of all healthcare professionals.

From news services and conference coverage, to expert interviews, our services support healthcare professionals in the knowledge they need to stay up to date on the latest trials and approvals, gain expert insight on current issues, and ensure the continued learning essential to improving patient care.

Portfolıo

Unrestricted oral feedings reported by caregivers and affected persons across severity of SMA

Maureen Lefton‐Greif talks about a study showing that unrestricted oral feeding – measured using a modified version of the FOIS scale – is more common in adults with less severe types of spinal muscular atrophy, and that some loss of function occurs over time.

Cushing’s Hub

A resource for healthcare professionals caring for patients with Cushing’s syndrome

Our valued medical sciences and society clients

view all clients

Headlines from across medwireNews

choose Specialty area from main menu for more

Patient Radiation proton therapy fixing mask showing laser lines for targeting cancer cells in the brain

09-12-2024|

|
Oncology |

Hypofractionated proton beam therapy regimen feasible for glioblastoma in older patients

A short course of hypofractionated proton beam therapy given alongside temozolomide may offer an improvement in overall survival for patients aged 65 years and older with a new diagnosis of glioblastoma, suggesting findings from a “hypothesis-generating” study.

Mother and daughter using laptop and tablet

02-12-2024|

Regular screening helps reduce symptom burden in paediatric cancer patients

Research shows that young people with a recent diagnosis of cancer benefit from completing an online symptom screening survey three times a week to help direct care.

Senior man going into CT scanner. CT scan technologist overlooking patient in Computed Tomography scanner during preparation for procedure

27-11-2024|

|
Oncology |

Routine postoperative imaging may improve pancreatic cancer survival

Research suggests that patients who are invited for routine imaging after pancreatic ductal adenocarcinoma resection have significantly longer overall survival than those who undergo imaging only after the development of symptoms.

15-11-2024|

|
Oncology |

Impact of haematological malignancy on pregnancy revealed

Women who are diagnosed with haematological malignancies during pregnancy have similar overall survival to peers diagnosed within a year of their pregnancy ending, indicates research published in The Lancet Haematology.

Physiotherapist assisting a patient with Amyotrophic Lateral Sclerosis

06-11-2024|

|
Neurology |

Adjunctive fasudil ‘considered safe’ for amyotrophic lateral sclerosis

The Rho-associated kinase inhibitor fasudil as an adjunct to riluzole is well tolerated for the treatment of patients with amyotrophic lateral sclerosis, indicate phase 2 findings from the ROCK-ALS study.

Young child getting an eye exam at clinic.

28-10-2024|

European retinoblastoma report shows stabilised incidence, high 5-year survival

The incidence of retinoblastoma in children in Europe stabilised between 2000 and 2013, say EUROCARE-6 Working Group investigators who report high 5-year survival rates in this population.